Macrophage function and stability of the atherosclerotic plaque: Progress report of a European project

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 12, Issue 1, 2002, Pages 3-11

  Bellosta, S ^a   Bernini, F ^b   Chinetti, G ^c   Cignarella, A ^a   Cullen, P ^d   Von Eckardstein, A ^e   Exley, A ^f   Freeth, J ^g   Goddard, M ^f   Hofker, M ^h   Kanters, E ^h   Kovanen, P ⁱ   Lorkowski, S ^d   Pentikainen M ⁱ   Printen, J ^g   Rauterberg, J ^d   Ritchie, A ^f   Staels, B ^c   Weitkamp, B ^d   De Winther, M ^j   Paoletti, Rodolfo ^a   Bellosta, Stefano ^a   more..

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c INSTITUT PASTEUR DE LILLE   (France)

^d UNIVERSITY OF MÜNSTER   (Germany)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f PAPWORTH HOSPITAL   (United Kingdom)

^g ASTRAZENECA   (United Kingdom)

^h MAASTRICHT UNIVERSITY   (Netherlands)

ⁱ Wihuri Institute   (Finland)

^j VU UNIVERSITY AMSTERDAM   (Netherlands)

more..

Author keywords

Atherosclerosis; Gene expression; Macrophage

Indexed keywords

ABC TRANSPORTER; CELL RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE CHEMOTACTIC FACTOR; TRANSCRIPTION FACTOR;

ANIMAL; ARTERIOSCLEROSIS; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE MODEL; ENZYMOLOGY; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; MACROPHAGE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; THROMBOSIS;

ANIMALS; ARTERIOSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; CHEMOTACTIC FACTORS, MACROPHAGE; CORONARY ARTERIOSCLEROSIS; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; HUMANS; INFLAMMATION; MACROPHAGES; NF-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; THROMBOSIS; TRANSCRIPTION FACTORS;

EID: 0036463896     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Brown BG, Zhao XQ, Sacco DE, Albers JJ (1993) Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 87: 1781-1791
2. Gronhøldt ML, Dalager-Pedersen S, Falk E (1998) Coronary atherosclerosis: determinants of plaque rupture. Eur Heart J 19: C24-C29
3. Bassiouny HS, Sakaguchi Y, Goudet CA, Vito R, Glagov S (1999) Pathobiology of symptomatic carotid atherosclerosis. In: Fuster V, Cornhill JF, Dinsmore RE, Fallon JT, Insull WJ, Libby P, Nissen S, Rosenfeld ME, Wagner WD (eds) The vulnerable atherosclerotic plaque: understanding, identification, and modification. Futura Publishing Company, New York, pp 25-44
4. Libby P (1995) Molecular bases of the acute coronary syndromes. Circulation 91: 2844-2850
5. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT (1994) Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 90: 775-778
6. Shah PK, Falk E, Badimon JJ, Fernandez Ortiz A, Mailhac A, Villareal Levy G, Fallon JT, Regnstrom J, Fuster V (1995) Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 92: 1565-1569
7. Xu XP, Meisel SR, Ong JM, Kaul S, Cercek B, Rajavashisth TB, Sharifi B, Shah PK (1999) Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation 99: 993-998
8. Saren P, Welgus HG, Kovanen PT (1996) TNF-α and IL-1β selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 157: 4159-4165
9. Dollery CM, McEwan JR, Henney AM (1995) Matrix metalloproteinases and cardiovascular disease. Circ Res 77: 863-868
10. Rosenson RS, Tangney CC (1998) Antiatherothrombotic properties of statins - Implications for cardiovascular event reduction. JAMA 279: 1643-1650
11. Conti CR (2001) Updated pathophysiologic concepts in unstable coronary artery disease. Am Heart J 141: 12-14
12. Campbell RW, Wallentin L, Verheugt FW, Turpie AG, Maseri A, Klein W, Cleland JG, Bode C, Becker R, Anderson J, Bertrand ME, Conti CR (1998) Management strategies for a better outcome in unstable coronary artery disease. Clin Cardiol 21: 314-322
13. Caligiuri G, Paulsson G, Nicoletti A, Maseri A, Hansson GK (2000) Evidence for antigen-driven T-cell response in unstable angina. Circulation 102: 1114-1119
14. Pentikainen MO, Oorni K, Ala-Korpela M, Kovanen PT (2000) Modified LDL - trigger of atherosclerosis and inflammation in the arterial intima. J Intern Med 247: 359-370
15. Kovanen PT, Mänttäri M (2001) Acute-phase response and thrombin generation in predicting coronary risk. Isr Med Assoc J 3: 36-38
16. Haider AW, Larson MG, O'Donnell CJ, Evans JC, Wilson PW, Levy D (1999) The association of chronic cough with the risk of myocardial infarction: the Framingham Heart Study. Am J Med 106: 279-284
17. Becher H, Grau A, Steindorf K, Buggle F, Hacke W (2000) Previous infection and other risk factors for acute cerebrovascular ischaemia: attributable risks and the characterisation of high risk groups. J Epidemiol Biostat 5: 277-283
18. Kunze AK, Annecke A, Wigger F, Lichy C, Buggle F, Schnippering H, Schnitzler P, Grau AJ (2000) Recent infection as a risk factor for intracerebral and subarachnoid hemorrhages. Cerebrovasc Dis 10: 352-358
19. Whicher J, Biasucci L, Rifai N (1999) Inflammation, the acute phase response and atherosclerosis. Clin Chem Lab Med 37: 495-503
20. van der Wal AC, Becker AE, van der Loos CM, Das PK (1994) Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89: 36-44
21. Kovanen PT, Kaartinen M, Paavonen T (1995) Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 92: 1084-1088
22. van der Wal AC, Piek JJ, de Boer OJ, Koch KT, Teeling P, van der Loos CM, Becker AE (1998) Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes. Heart 80: 14-18
23. Kaartinen M, van der Wal AC, van der Loos CM, Piek JJ, Koch KT, Becker AE, Kovanen PT (1998) Mast cell infiltration in acute coronary syndromes: implications for plaque rupture. J Am Coll Cardiol 32: 606-612
24. van der Wal AC, Becker AE, Koch KT, Pick JJ, Teeling P, van der Loos CM, David GK (1996) Clinically stable anginapectoris is not necessarily associated with histologically stable atherosclerotic plaques. Heart 76: 312-316
25. Jude B, Agraou B, McFadden EP, Susen S, Bauters C, Lepelley P, Vanhaesbroucke C, Devos P, Cosson A, Asseman P (1994) Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina. Circulation 90: 1662-1668
26. Stemme S, Rymo L, Hansson GK (1991) Polyclonal origin of T lymphocytes in human atherosclerotic plaques. Lab Invest 65: 654-660
27. Uyemura K, Demer LL, Castle SC, Jullien D, Berliner JA, Gately MK, Warrier RR, Pham N, Fogelman AM, Modlin RL (1996) Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest 97: 2130-2138
28. de Boer OJ, van der Wal AC, Becker AE (2000) Atherosclerosis, inflammation, and infection. J Pathol 190: 237-243
29. Liuzzo G, Kopecky SL, Frye RL, O'Fallon WM, Maseri A, Goronzy JJ, Weyand CM (1999) Perturbation of the T-cell repertoire in patients with unstable angina. Circulation 100: 2135-2139
30. Klucken J, Büchler C, Orsó E, Kaminksi WE, Porsch-Özcürümez M, Liebisch G, Kapinsky M, Diederich W, Drobnik W, Dean M, Allikmets R, Schmitz G (2000) ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc Natl Acad Sci USA 97: 817-822
31. Lorkowski S, Kratz M, Wenner C, Schmidt R, Weitkamp B, Fobker M, Reinhardt J, Rauterberg J, Galinski EA, Cullen P (2001) Expression of the ATP-binding cassette transporter gene ABCG1 (ABC8) in Tangier disease. Biochem Biophys Res Commun 283: 821-830
32. Lorkowski S, Rust S, Engel T, Jung E, Tegelkamp K, Galinski EA, Assmann G, Cullen P (2001) Genomic sequence and structure of the human ABCG1 (ABC8) gene. Biochem Biophys Res Commun 280: 121-131
33. Lee MH, Lu K, Hazard S, Yu H, Shulenin S, Hidaka H, Kojima H, Allikmets R, Sakuma N, Pegoraro R, Srivastava AK, Salen G, Dean M, Patel SB (2001) Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 27: 79-83
34. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, Kwiterovich P, Shan B, Barnes R, Hobbs HH (2000) Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290: 1771-1775
35. Von Eckardstein A, Langer C, Engel T, Schaukal I, Cignarella A, Reinhardt J, Lorkowski S, Li Z, Zhou X, Cullen P, Assmann G (2001) ATP binding cassette transporter ABCA1 modulates the secretion of apolipoprotein E from human monocyte-derived macrophages. FASEB J 15: 1555-1561
36. Ishigami M, Swertfeger DK, Hui MS, Granholm NA, Hui DY (2000) Apolipoprotein E inhibition of vascular smooth muscle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 20: 1020-1026
37. Stannard AK, Riddell DR, Bradley NJ, Hassall DG, Graham A, Owen JS (1998) Apolipoprotein E and regulation of cytokine-induced cell adhesion molecule expression in endothelial cells. Atherosclerosis 139: 57-64
38. Cignarella A, Brennhausen B, von Eckardstein A, Assmann G, Cullen P (1998) Differential effects of lovastatin on the trafficking of endogenous and lipoprotein-derived cholesterol in human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 18: 1322-1329
39. Bernini F, Canavesi M, Bernardini E, Scurati N, Bellosta S, Fumagalli R (1997) Effect of lacidipine on cholesterol esterification: in vivo and in vitro studies. Br J Pharmacol 122: 1209-1215
40. Bellosta S, Canavesi M, Favari E, Cominacini L, Gaviraghi G, Fumagalli R, Paoletti R, Bernini F (2001) Lacidipine [correction of Lalsoacidipine] modulates the secretion of matrix metalloproteinase-9 by human macrophages. J Pharmacol Exp Ther 296: 736-743
41. Bellosta S, Via D, Canavesi M, Pfister P, Fumagalli R, Paoletti R, Bernini F (1998) HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. Arterioscler Thromb Vasc Biol 18: 1671-1678
42. Pineda Torra I, Gervois P, Staels B (1999) Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging. Curr Opin Lipidol 10: 151-159
43. Fruchart JC, Duriez P, Staels B (1999) Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis. Curr Opin Lipidol 10: 245-257
44. Neve BP, Fruchart J, Staels B (2000) Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis. Biochem Pharmacol 60: 1245-1250
45. Jiang C, Ting AT, Seed B (1998) PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86
46. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK (1998) The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79-82
47. Chinetti G, Griglio S, Antonucci M, Torra IP, Delerive P, Majd Z, Fruchart JC, Chapman J, Najib J, Staels B (1998) Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J Biol Chem 273: 25573-25580
48. Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, Teissier E, Minnich A, Jaye M, Duverger N, Brewer HB, Fruchart JC, Clavey V, Staels B (2001) PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 7: 53-58
49. Baeuerle PA, Baltimore D (1996) NF kappa-B: ten years after. Cell 87: 13-20
50. Brand K, Page S, Rogler G, Bartsch A, Brandl R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, Neumeier D (1996) Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 97: 1715-1722
51. Barnes MJ, Farndale RW (1999) Collagens and atherosclerosis. Exp Gerontol 34: 513-525
52. Weitkamp B, Cullen P, Plenz G, Robenek H, Rauterberg J (1999) Human macrophages synthesize type VIII collagen in vitro and in the atherosclerotic plaque. FASEB J 13: 1445-1457
53. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW (1995) A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on arteriosclerosis, American Heart Association. Circulation 92: 1355-1374
54. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM (2000) Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20: 1262-1275
55. Ross R (1999) Atherosclerosis, an inflammatory disease. New Engl J Med 340: 115-126
56. Ross R (1993) The pathogenesis of atherosclerosis, a perspective for the 1990s. Nature 362: 801-809